Vaccines Market by Technology (Conjugate Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Inactivated and Subunit Vaccines and Recombinant Vaccines), Strain/Serotype (Monovalent Vaccines and Multivalent Vaccines), Vaccine Type (Hepatitis, DT containing (including Polio), Pneumococcal Conjugate Vaccine (PCV), Meningococcal, Human Papillomavirus (HPV), Rotavirus, Influenza, Measles, Mumps, Rubella, Varicella, BCG, Cholera, IPV (Inactivated Polio Vaccine), OPV (Oral Poliovirus Vaccines), JE (Japanese Encephalitis), YF (Yellow Fever), Shingles, Typhoid, Rabies), Route of Administration (Oral Administration, and Intramuscular & Subcutaneous Administration) and Patient Type (Pediatric Patients, Adult Patients) – Analysis & Forecast 2019-2030

Report ID : 81  |  Published Date : May 2019  |  Pages : 255  |  Region : Global  |  Report Code : PH-3





Vaccines Market Overview and Introduction

Vaccines market is expected to be valued at US$ 36,297.2 Mn in 2019 and is anticipated to grow at a CAGR of 6.0% from 2019 to 2030.

Vaccines are biological preparations which are used to boost immunity by activating acquired immunity against a particular disease. Vaccines typically constitutes of agents resembling a disease-causing microorganism. It is fabricated from either a weakened or killed form of the microbe, its surface protein or toxins. The process of administration of vaccine is known as vaccination. The vaccination agent assists the body in recognizing the agent as a threat and destroys it. Moreover, it helps the body to recognize and destroy any microorganism associated with the agent for future encounters.

Rising incidences and prevalence of several diseases, namely hepatitis, tuberculosis, influenza and cholera is anticipated to ensure a strong demand for vaccination products worldwide. Similarly, growing support from both government and non-government establishments have been pivotal in contributing the growth of the global vaccines market. Moreover, growing initiatives to support immunization drives across developing economies, economies in transition and developed economies to control and eradicate vaccine-preventable diseases can primarily be attributed for the extensive adoption of vaccines globally. However, high costs associated with development, storage is likely to restrain the market to a certain extent.

Vaccines Market

Vaccines Market by Technology

On the basis of technology, the vaccines market can be segmented into conjugate vaccines, live attenuated vaccines, toxoid vaccines, inactivated and subunit vaccines and recombinant vaccines. The conjugate vaccine segment accounted for the largest market share in the global vaccines market, owing to rising company investments and growing government support for development of conjugate vaccines.

Vaccines Market by Strain/Serotype

On the basis of type, the market is segmented into monovalent vaccines and multivalent vaccines. In terms of market share, the segment of monovalent vaccines accounted for the largest share. Growing adoption of monovalent vaccines for combating single diseases, namely dengue, influenza and malaria among others can be attributed to the extensive growth of this segment.

Vaccines Market by Vaccine Type

Similarly, in terms of disease indication the vaccines market can be segmented into Hepatitis, DT containing (including Polio), Pneumococcal Conjugate Vaccine (PCV), Meningococcal, Human Papillomavirus (HPV), Rotavirus, Influenza, Measles, Mumps, Rubella, Varicella, BCG, Cholera, IPV (Inactivated Polio Vaccine), OPV (Oral Poliovirus Vaccines), JE (Japanese Encephalitis), YF (Yellow Fever), Shingles, Typhoid, Rabies and other vaccine types

Vaccines Market by Route of Administration

Whereas, the route of administration segment can be classified broadly into three categories, namely oral administration, intramuscular and subcutaneous administration and other routes of administrations. Finally, based on end user the global vaccines market can be segmented into pediatric patients and adult patients.

Vaccines Market by Patient Type  

The segment of patient type can be broadly classified into pediatrics and adults. Widescale administraion of different types of vaccines among pediatric population, and active participation of both public & private establishments to carry out vaccine initiaves is anticipated to contribute significantly to the growth of the segment in the coming years.

Vaccines Market by Region

The global vaccines market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). North America dominated the market of vaccines market, followed by Europe and Asia Pacific. Asia Pacific is expected to dominate the global vaccines market in the forecast period. Factors such as the increasing investments by market players in emerging economies, rising incidence of diseases, and growing awareness regarding vaccinations to drive market growth in this region 

Vaccines Market Prominent Players

The prominent players in the global vaccines market are Pfizer Inc., GlaxoSmithKline plc., Merck & Co., Inc., Sanofi Pasteur Limited (Sanofi), AstraZeneca, CSL Limited, Bavarian Nordic, Panacea Biotec Limited, PT Bio Farma (Persero) and Serum Institute of India Pvt. Ltd. among others

Table of Contents

  1. INTRODUCTION
    1. Market Definition
    2. Market Ecosystem
      1. Market Classification
      2. Geographic Scope
      3. Years Considered for the Study: Historical Years – 2016 & 2017; Base Year – 2018; Forecasted Years – 2019 to 2030
    3. Currency Used
  2. RESEARCH METHODOLOGY
    1. Research Framework
    2. Data Collection Technique
    3. Data Sources
      1. Secondary Sources
      2. Primary Sources
    4. Market Estimation Methodology
      1. Bottom Up Approach
      2. Top Down Approach
    5. Data Validation and Triangulation
      1. Market Forecasting Model
      2. Limitations/Assumptions of the Study
  3. ABSTRACT OF THE STUDY
  4. MARKET DYNAMICS ASSESMENT
    1. Overview
    2. Drivers
    3. Barriers/Challenges
    4. Opportunities
  5. UNIQUE SELLING PROPOSITIONS (USPs)
    1. Pipeline  Assessment
    2. Epidemiological Assessment: Infectious Diseases
    3. Market Potential Assessment, By Disease Indication
      1. Respiratory Syncytial Virus (RSV)
      2. Cytomegalovirus
      3. Dengue
    4. Vaccines Purchase Data By GAVI (Historical & Forecasted)
  6. GLOBAL VACCINES MARKET- ANALYSIS & FORECAST, BY TECHNOLOGY
    1. Conjugate Vaccines
    2. Live Attenuated Vaccines
    3. Toxoid Vaccines
    4. Inactivated and Subunit Vaccines 
    5. Recombinant Vaccines 
  7. GLOBAL VACCINES MARKET - ANALYSIS & FORECAST, BY STRAIN/SEROTYPE
    1. Monovalent Vaccines 
    2. Multivalent Vaccines
  8. GLOBAL VACCINES MARKET - ANALYSIS & FORECAST, BY VACCINE TYPE
    1. Hepatitis
    2. DT containing
    3. Pneumococcal Conjugate Vaccine (PCV)
    4. Meningococcal
    5. Human Papillomavirus (HPV)
    6. Rotavirus
    7. Influenza
    8. Measles, Mumps, Rubella, Varicella
    9. BCG
    10. Cholera
    11. IPV (Inactivated Polio Vaccine)
    12. OPV (Oral Poliovirus Vaccines)
    13. JE (Japanese Encephalitis)
    14. YF (Yellow Fever)
    15. Shingles
    16. Typhoid
    17. Rabies
    18. Others
  9. GLOBAL MARKET - ANALYSIS & FORECAST, BY ROUTE OF ADMINISTRATION
    1. Oral Administration
    2. Intramuscular and Subcutaneous Administration 
    3. Other Routes of Administrations
  10. GLOBAL MARKET - ANALYSIS & FORECAST, BY PATIENT TYPE
    1. Pediatric Patients 
    2. Adult Patients
  11. GLOBAL MARKET - ANALYSIS & FORECAST, BY REGION
    1. North America Vaccines Market
      1. North America Market, By Country
        1.  US
        2.  Canada
      2. North America Market Analysis & Forecast, By Technology
      3. North America Market Analysis & Forecast, By Strain/Serotype
      4. North America Market Analysis & Forecast, By Vaccine Group
      5. North America Market Analysis & Forecast, By Route Of Administration
      6. North America Market Analysis & Forecast, By Patient Type
    2. Europe Vaccines Market
      1. Europe Market, By Country/Region
        1. Germany
        2. U.K
        3. France
        4. Rest of Europe (ROE)
      2. Europe Market Analysis & Forecast, By Technology
      3. Europe Market Analysis & Forecast, By Strain/Serotype
      4. Europe Market Analysis & Forecast, By Vaccine Group
      5. Europe Market Analysis & Forecast, By Route Of Administration
      6. Europe Market Analysis & Forecast, By Patient Type
    3. Asia Pacific Vaccines Market
      1. Asia Pacific Market, By Country/Region
        1. China
        2. Japan
        3. India
        4. Rest of Asia Pacific (RoAPAC)
      2. Asia Pacific Market Analysis & Forecast, By Technology
      3.  Asia Pacific Market Analysis & Forecast, By Strain/Serotype
      4. Asia Pacific Market Analysis & Forecast, By Vaccine Group
      5. Asia Pacific Market Analysis & Forecast, By Route Of Administration
      6. Asia Pacific Market Analysis & Forecast, By Patient Type
    4. Rest of the World (ROW) Vaccines Market
      1. Rest of the World Market, By Country/ Region
        1. Latin America
        2. Middle East & Africa
      2. Rest of the World Market Analysis & Forecast, By Technology
      3. Rest of the World Market Analysis & Forecast, By Strain/Serotype
      4. Rest of the World Market Analysis & Forecast, By Vaccine Group
      5. Rest of the World Market Analysis & Forecast, By Route Of Administration
      6. Rest of the World Market Analysis & Forecast, By Patient Type
  12. COMPETETIVE LANDSCAPE
    1. Key Players & Their Competitive Positioning (2018)
    2. Vaccine Revenue Forecast, By Major Companies
    3. Key Strategies Assessment
      1. New Product Launches/Product Launches/Product Approvals
      2. Agreements/Acquisitions/Collaborations/Partnerships
      3. Expansions
  13. COMPANY PROFILES (Business Overview, Products Offered, Financial Performance*, Recent Developments)
    1.  Pfizer Inc.
    2. GlaxoSmithKline plc.
    3. Merck & Co., Inc. 
    4.  Sanofi Pasteur Limited(Sanofi)
    5. AstraZeneca
    6.  CSL Limited
    7.  Bavarian Nordic
    8.  Panacea Biotec Limited  
    9.  PT Bio Farma (Persero)
    10.  Serum Institute of India Pvt. Ltd.

*Financial details might not be captured in case of privately-held companies or for companies that do not report this information in public domain